{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:12:47Z","timestamp":1789560767079,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002597","name":"Kyung Hee University","doi-asserted-by":"publisher","award":["GS-1-JO-ON-20250507"],"award-info":[{"award-number":["GS-1-JO-ON-20250507"]}],"id":[{"id":"10.13039\/501100002597","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12764-0","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:00:31Z","timestamp":1789560031000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synergistic restoration of NK cell cytotoxicity against solid tumors via sLTA-mediated dual-action modulation"],"prefix":"10.1007","volume":"53","author":[{"given":"Dobin","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeoungeun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6463-756X","authenticated-orcid":false,"given":"Hangeun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Kyun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"12764_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/ni1581","volume":"9","author":"LL Lanier","year":"2008","unstructured":"Lanier LL (2008) Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 9:495\u2013502. https:\/\/doi.org\/10.1038\/ni1581","journal-title":"Nat Immunol"},{"key":"12764_CR2","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3389\/fimmu.2017.01124","volume":"8","author":"S Paul","year":"2017","unstructured":"Paul S, Lal G (2017) The molecular mechanism of natural killer cells function and its importance in cancer immunotherapy. Front Immunol 8:1124. https:\/\/doi.org\/10.3389\/fimmu.2017.01124","journal-title":"Front Immunol"},{"key":"12764_CR3","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.3389\/fimmu.2019.03038","volume":"10","author":"O Melaiu","year":"2020","unstructured":"Melaiu O, Lucarini V, Cifaldi L, Fruci D (2020) Influence of the tumor microenvironment on NK cell function in solid tumors. Front Immunol 10:3038. https:\/\/doi.org\/10.3389\/fimmu.2019.03038","journal-title":"Front Immunol"},{"key":"12764_CR4","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1172\/JCI200215950","volume":"110","author":"R Parihar","year":"2002","unstructured":"Parihar R, Dierksheide J, Hu Y, Carson WE (2002) IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells. J Clin Invest 110:983\u2013992. https:\/\/doi.org\/10.1172\/JCI200215950","journal-title":"J Clin Invest"},{"key":"12764_CR5","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-07-4750","volume":"14","author":"MJ Robertson","year":"2008","unstructured":"Robertson MJ, Kirkwood JM, Logan TF, Koch KM, Kathman S, Kirby LC, Bell WN, Thurmond LM, Weisenbach J, Dar MM (2008) A dose-escalation study of recombinant human interleukin-18 using two different schedules of administration in patients with cancer. Clin Cancer Res 14:3462\u20133469. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-4750","journal-title":"Clin Cancer Res"},{"key":"12764_CR6","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.cyto.2011.09.028","volume":"56","author":"KP Han","year":"2011","unstructured":"Han KP, Zhu X, Liu B, Jeng E, Kong L, Yovandich JL, Vyas VV, Marcus WD, Chavaillaz PA, Romero CA et al (2011) IL-15:IL-15 receptor alpha superagonist complex: high-level co-expression in recombinant mammalian cells, purification and characterization. Cytokine 56:804\u2013810. https:\/\/doi.org\/10.1016\/j.cyto.2011.09.028","journal-title":"Cytokine"},{"key":"12764_CR7","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1200\/JCO.2007.14.5193","volume":"26","author":"JA Thompson","year":"2008","unstructured":"Thompson JA, Curti BD, Redman BG, Bhatia S, Weber JS, Agarwala SS, Sievers EL, Hughes SD, DeVries TA, Hausman DF (2008) Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinoma. J Clin Oncol 26:2034\u20132039. https:\/\/doi.org\/10.1200\/JCO.2007.14.5193","journal-title":"J Clin Oncol"},{"key":"12764_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S1473-3099(02)00226-8","volume":"2","author":"I Ginsburg","year":"2002","unstructured":"Ginsburg I (2002) Role of lipoteichoic acid in infection and inflammation. Lancet Infect Dis 2:171\u2013179. https:\/\/doi.org\/10.1016\/S1473-3099(02)00226-8","journal-title":"Lancet Infect Dis"},{"key":"12764_CR9","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s12272-016-0804-y","volume":"39","author":"SS Kang","year":"2016","unstructured":"Kang SS, Sim JR, Yun CH, Han SH (2016) Lipoteichoic acids as a major virulence factor causing inflammatory responses via Toll-like receptor 2. Arch Pharm Res 39:1519\u20131529. https:\/\/doi.org\/10.1007\/s12272-016-0804-y","journal-title":"Arch Pharm Res"},{"key":"12764_CR10","doi-asserted-by":"publisher","first-page":"5921","DOI":"10.3390\/ijms22115921","volume":"22","author":"G Kim","year":"2021","unstructured":"Kim G, Choi KH, Kim H, Chung DK (2021) Alleviation of LPS-induced inflammation and septic shock by Lactiplantibacillus plantarum K8 lysates. Int J Mol Sci 22:5921. https:\/\/doi.org\/10.3390\/ijms22115921","journal-title":"Int J Mol Sci"},{"key":"12764_CR11","doi-asserted-by":"publisher","first-page":"104360","DOI":"10.1016\/j.micpath.2020.104360","volume":"147","author":"Y Kim","year":"2020","unstructured":"Kim Y, Park JY, Kim H, Chung DK (2020) Differential role of lipoteichoic acids isolated from Staphylococcus aureus and Lactobacillus plantarum on the aggravation and alleviation of atopic dermatitis. Microb Pathog 147:104360. https:\/\/doi.org\/10.1016\/j.micpath.2020.104360","journal-title":"Microb Pathog"},{"key":"12764_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4014\/jmb.1809.09001","volume":"29","author":"JE Ahn","year":"2019","unstructured":"Ahn JE, Kim H, Chung DK (2019) Lipoteichoic acid isolated from Lactobacillus plantarum maintains inflammatory homeostasis through regulation of Th1- and Th2-induced cytokines. J Microbiol Biotechnol 29:151\u2013159. https:\/\/doi.org\/10.4014\/jmb.1809.09001","journal-title":"J Microbiol Biotechnol"},{"key":"12764_CR13","doi-asserted-by":"publisher","first-page":"fnw140","DOI":"10.1093\/femsle\/fnw140","volume":"363","author":"B Jeon","year":"2016","unstructured":"Jeon B, Kim HR, Kim H, Chung DK (2016) In vitro and in vivo downregulation of C3 by lipoteichoic acid isolated from Lactobacillus plantarum K8 suppressed cytokine-mediated complement system activation. FEMS Microbiol Lett 363:fnw140. https:\/\/doi.org\/10.1093\/femsle\/fnw140","journal-title":"FEMS Microbiol Lett"},{"key":"12764_CR14","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.4014\/jmb.2002.02032","volume":"30","author":"C Chen","year":"2020","unstructured":"Chen C, Li H (2020) The inhibitory effect of gut microbiota and its metabolites on colorectal cancer. J Microbiol Biotechnol 30:1607\u20131613. https:\/\/doi.org\/10.4014\/jmb.2002.02032","journal-title":"J Microbiol Biotechnol"},{"key":"12764_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1017\/S0007114512001232","volume":"109","author":"FS Weill","year":"2013","unstructured":"Weill FS, Cela EM, Paz ML, Ferrari A, Leoni J, Gonz\u00e1lez Maglio DH (2013) Lipoteichoic acid from Lactobacillus rhamnosus GG as an oral photoprotective agent against UV-induced carcinogenesis. Br J Nutr 109:457\u2013466. https:\/\/doi.org\/10.1017\/S0007114512001232","journal-title":"Br J Nutr"},{"key":"12764_CR16","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.4049\/jimmunol.180.4.2553","volume":"180","author":"HG Kim","year":"2008","unstructured":"Kim HG, Kim NR, Gim MG, Lee JM, Lee SY, Ko MY, Kim JY, Han SH, Chung DK (2008) Lipoteichoic acid isolated from Lactobacillus plantarum inhibits lipopolysaccharide-induced TNF-\u03b1 production in THP-1 cells and endotoxin shock in mice. J Immunol 180:2553\u20132561. https:\/\/doi.org\/10.4049\/jimmunol.180.4.2553","journal-title":"J Immunol"},{"key":"12764_CR17","doi-asserted-by":"publisher","first-page":"296","DOI":"10.4149\/BLL_2015_057","volume":"116","author":"M Gharagozloo","year":"2015","unstructured":"Gharagozloo M, Kalantari H, Rezaei A, Maracy MR, Salehi M, Bahador A, Hassannejad N, Narimani M, Sanei MH, Bayat B et al (2015) The decrease in NKG2D+ natural killer cells in peripheral blood of patients with metastatic colorectal cancer. Bratisl Lek Listy 116:296\u2013301. https:\/\/doi.org\/10.4149\/BLL_2015_057","journal-title":"Bratisl Lek Listy"},{"key":"12764_CR18","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3389\/fimmu.2017.00930","volume":"8","author":"Y Wu","year":"2017","unstructured":"Wu Y, Tian Z, Wei H (2017) Developmental and functional control of natural killer cells by cytokines. Front Immunol 8:930. https:\/\/doi.org\/10.3389\/fimmu.2017.00930","journal-title":"Front Immunol"},{"key":"12764_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/sj.cdd.4400476","volume":"6","author":"AG Porter","year":"1999","unstructured":"Porter AG, J\u00e4nicke RU (1999) Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6:99\u2013104. https:\/\/doi.org\/10.1038\/sj.cdd.4400476","journal-title":"Cell Death Differ"},{"key":"12764_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1189\/jlb.0611304","volume":"91","author":"R Wang","year":"2012","unstructured":"Wang R, Jaw JJ, Stutzman NC, Zou Z, Sun PD (2012) Natural killer cell-produced IFN-\u03b3 and TNF-\u03b1 induce target cell cytolysis through up-regulation of ICAM-1. J Leukoc Biol 91:299\u2013309. https:\/\/doi.org\/10.1189\/jlb.0611304","journal-title":"J Leukoc Biol"},{"key":"12764_CR21","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.3324\/haematol.12937","volume":"93","author":"EM Dunbar","year":"2008","unstructured":"Dunbar EM, Buzzeo MP, Levine JB, Schold JD, Meier-Kriesche HU, Reddy V (2008) The relationship between circulating natural killer cells after reduced intensity conditioning hematopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease. Haematologica 93:1852\u20131858. https:\/\/doi.org\/10.3324\/haematol.12937","journal-title":"Haematologica"},{"key":"12764_CR22","doi-asserted-by":"publisher","first-page":"6287","DOI":"10.1158\/1078-0432.CCR-11-1347","volume":"17","author":"MR Parkhurst","year":"2011","unstructured":"Parkhurst MR, Riley JP, Dudley ME, Rosenberg SA (2011) Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression. Clin Cancer Res 17:6287\u20136297. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-1347","journal-title":"Clin Cancer Res"},{"key":"12764_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s12026-012-8285-7","volume":"52","author":"G Konjevic","year":"2012","unstructured":"Konjevic G, Jurisic V, Jovic V, Vuletic A, Mirjacic Martinovic K, Radenkovic S, Spuzic I (2012) Investigation of NK cell function and their modulation in different malignancies. Immunol Res 52:139\u2013156. https:\/\/doi.org\/10.1007\/s12026-012-8285-7","journal-title":"Immunol Res"},{"key":"12764_CR24","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/bjh.14001","volume":"173","author":"MJ Barth","year":"2016","unstructured":"Barth MJ, Chu Y, Hanley PJ, Cairo MS (2016) Immunotherapeutic approaches for the treatment of childhood, adolescent and young adult non-Hodgkin lymphoma. Br J Haematol 173:597\u2013616. https:\/\/doi.org\/10.1111\/bjh.14001","journal-title":"Br J Haematol"},{"key":"12764_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1159\/000325465","volume":"3","author":"A Stojanovic","year":"2011","unstructured":"Stojanovic A, Cerwenka A (2011) Natural killer cells and solid tumors. J Innate Immun 3:355\u2013364. https:\/\/doi.org\/10.1159\/000325465","journal-title":"J Innate Immun"},{"key":"12764_CR26","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1002\/eji.201344272","volume":"44","author":"M Vitale","year":"2014","unstructured":"Vitale M, Cantoni C, Pietra G, Mingari MC, Moretta L (2014) Effect of tumor cells and tumor microenvironment on NK-cell function. Eur J Immunol 44:1582\u20131592. https:\/\/doi.org\/10.1002\/eji.201344272","journal-title":"Eur J Immunol"},{"key":"12764_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0022-1759(03)00266-0","volume":"279","author":"R Sun","year":"2003","unstructured":"Sun R, Fan J, Wei H, Zhang C, Tian Z (2003) Use of interleukin-15 for preparation of adherent NK cells from human peripheral blood: comparison with interleukin-2. J Immunol Methods 279:79\u201390. https:\/\/doi.org\/10.1016\/S0022-1759(03)00266-0","journal-title":"J Immunol Methods"},{"key":"12764_CR28","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.humimm.2011.07.311","volume":"72","author":"AH Pillet","year":"2011","unstructured":"Pillet AH, Theze J, Rose T (2011) Interleukin (IL)-2 and IL-15 have different effects on human natural killer lymphocytes. Hum Immunol 72:1013\u20131017. https:\/\/doi.org\/10.1016\/j.humimm.2011.07.311","journal-title":"Hum Immunol"},{"key":"12764_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/sj.bmt.1704101","volume":"32","author":"LJ Burns","year":"2003","unstructured":"Burns LJ, Weisdorf DJ, DeFor TE, Vesole DH, Repka TL, Blazar BR, Burger SR, Panoskaltsis-Mortari A, Keever-Taylor CA, Zhang MJ et al (2003) IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I\/II trial. Bone Marrow Transpl 32:177\u2013186. https:\/\/doi.org\/10.1038\/sj.bmt.1704101","journal-title":"Bone Marrow Transpl"},{"key":"12764_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/00002371-199308000-00012","volume":"14","author":"HJ Zeh 3rd","year":"1993","unstructured":"Zeh HJ 3rd, Hurd S, Storkus WJ, Lotze MT (1993) Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: implications for the immunotherapy of cancer. J Immunother Emphas Tumor Immunol 14:155\u2013161. https:\/\/doi.org\/10.1097\/00002371-199308000-00012","journal-title":"J Immunother Emphas Tumor Immunol"},{"key":"12764_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s002620050245","volume":"42","author":"U Sahin","year":"1996","unstructured":"Sahin U, Kraft-Bauer S, Ohnesorge S, Pfreundschuh M, Renner C (1996) Interleukin-12 increases bispecific-antibody-mediated natural killer cell cytotoxicity against human tumors. Cancer Immunol Immunother 42:9\u201314. https:\/\/doi.org\/10.1007\/s002620050245","journal-title":"Cancer Immunol Immunother"},{"key":"12764_CR32","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1002\/eji.200939718","volume":"40","author":"S Haeberlein","year":"2010","unstructured":"Haeberlein S, Sebald H, Bogdan C, Schleicher U (2010) IL-18, but not IL-15, contributes to the IL-12-dependent induction of NK-cell effector functions by Leishmania infantum in vivo. Eur J Immunol 40:1708\u20131717. https:\/\/doi.org\/10.1002\/eji.200939718","journal-title":"Eur J Immunol"},{"key":"12764_CR33","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1089\/jir.2006.26.706","volume":"26","author":"DL Hodge","year":"2006","unstructured":"Hodge DL, Subleski JJ, Reynolds DA, Buschman MD, Schill WB, Burkett MW, Malyguine AM, Young HA (2006) The proinflammatory cytokine interleukin-18 alters multiple signaling pathways to inhibit natural killer cell death. J Interferon Cytokine Res 26:706\u2013718. https:\/\/doi.org\/10.1089\/jir.2006.26.706","journal-title":"J Interferon Cytokine Res"},{"key":"12764_CR34","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1158\/0008-5472.CAN-12-2357","volume":"73","author":"W Xu","year":"2013","unstructured":"Xu W, Jones M, Liu B, Zhu X, Johnson CB, Edwards AC, Kong L, Jeng EK, Han K, Marcus WD et al (2013) Efficacy and mechanism-of-action of a novel superagonist interleukin-15: interleukin-15 receptor alphaSu\/Fc fusion complex in syngeneic murine models of multiple myeloma. Cancer Res 73:3075\u20133086. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-2357","journal-title":"Cancer Res"},{"key":"12764_CR35","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1158\/1538-7445.AM2017-1603","volume":"77","author":"P Kuo","year":"2017","unstructured":"Kuo P, Maiti M, Quach P, Addepalli M, Lanka A, Mathamsetti P, Fanton C, Zhang P, Kirk P, Miyazaki T et al (2017) NKTR-255 engages the IL-15 pathway driving CD8 T cell survival and CD8 memory T cell proliferation. Cancer Res 77:1603. https:\/\/doi.org\/10.1158\/1538-7445.AM2017-1603","journal-title":"Cancer Res"},{"key":"12764_CR36","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3389\/fimmu.2015.00368","volume":"6","author":"W Wang","year":"2015","unstructured":"Wang W, Erbe AK, Hank JA, Morris ZS, Sondel PM (2015) NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy. Front Immunol 6:368. https:\/\/doi.org\/10.3389\/fimmu.2015.00368","journal-title":"Front Immunol"},{"key":"12764_CR37","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1158\/1535-7163.MCT-12-1182","volume":"12","author":"S Herter","year":"2013","unstructured":"Herter S, Herting F, Mundigl O, Waldhauer I, Weinzierl T, Fauti T, Muth G, Ziegler-Landesberger D, Van Puijenbroek E, Lang S et al (2013) Preclinical activity of the type II CD20 antibody GA101 (obinutuzumab) compared with rituximab and ofatumumab in vitro and in xenograft models. Mol Cancer Ther 12:2031\u20132042. https:\/\/doi.org\/10.1158\/1535-7163.MCT-12-1182","journal-title":"Mol Cancer Ther"},{"key":"12764_CR38","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3109\/09553002.2013.765617","volume":"89","author":"IF Voutsas","year":"2013","unstructured":"Voutsas IF, Mahaira LG, Fotopoulou K, Kapranos N, Reclos JG, Gritzapis AD, Papamichail M, Perez SA, Baxevanis CN (2013) Gamma-irradiation induces HER-2\/neu overexpression in breast cancer cell lines and sensitivity to treatment with trastuzumab. Int J Radiat Biol 89:319\u2013325. https:\/\/doi.org\/10.3109\/09553002.2013.765617","journal-title":"Int J Radiat Biol"},{"key":"12764_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1189\/jlb.69.1.81","volume":"69","author":"B Jahrsdorfer","year":"2001","unstructured":"Jahrsdorfer B, Hartmann G, Racila E, Jackson W, Muhlenhoff L, Meinhardt G, Endres S, Link BK, Krieg AM, Weiner GJ (2001) CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigens. J Leukoc Biol 69:81\u201388. https:\/\/doi.org\/10.1189\/jlb.69.1.81","journal-title":"J Leukoc Biol"},{"key":"12764_CR40","doi-asserted-by":"publisher","first-page":"293","DOI":"10.48022\/mbl.2112.12003","volume":"50","author":"B Jeon","year":"2022","unstructured":"Jeon B, Kim H, Chung DK (2022) Lipoteichoic acid isolated from Staphylococcus aureus induced THP-1 cell apoptosis through an autocrine mechanism of cytokines and SOCS-1-mediated Bcl2 inhibition. Microbiol Biotechnol Lett 50:293\u2013300. https:\/\/doi.org\/10.48022\/mbl.2112.12003","journal-title":"Microbiol Biotechnol Lett"},{"key":"12764_CR41","first-page":"2809","volume":"47","author":"JH Schiller","year":"1987","unstructured":"Schiller JH, Bittner G, Storer B, Willson JK (1987) Synergistic antitumor effects of tumor necrosis factor and gamma-interferon on human colon carcinoma cell lines. Cancer Res 47:2809\u20132813 PMID: 3105867","journal-title":"Cancer Res"},{"key":"12764_CR42","doi-asserted-by":"publisher","first-page":"e12441","DOI":"10.1111\/cpr.12441","volume":"51","author":"J Shen","year":"2018","unstructured":"Shen J, Xiao Z, Zhao Q, Li M, Wu X, Zhang L, Hu W, Cho CH (2018) Anti-cancer therapy with TNF\u03b1 and IFN\u03b3: A comprehensive review. Cell Prolif 51:e12441. https:\/\/doi.org\/10.1111\/cpr.12441","journal-title":"Cell Prolif"},{"key":"12764_CR43","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.3390\/microorganisms9061135","volume":"9","author":"BJ Jung","year":"2021","unstructured":"Jung BJ, Kim H, Jang KO, Kim S, Chung DK (2021) Lipoteichoic acid from Staphylococcus aureus activates the complement system via C3 induction and CD55 inhibition. Microorganisms 9:1135. https:\/\/doi.org\/10.3390\/microorganisms9061135","journal-title":"Microorganisms"},{"key":"12764_CR44","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jmii.2020.12.011","volume":"55","author":"H Kim","year":"2022","unstructured":"Kim H, Kim HE, Chung DK, Jang KO (2022) Manganese superoxide dismutase induced by lipoteichoic acid isolated from Staphylococcus aureus regulates cytokine production in THP-1 cells. J Microbiol Immunol Infect 55:36\u201343. https:\/\/doi.org\/10.1016\/j.jmii.2020.12.011","journal-title":"J Microbiol Immunol Infect"},{"key":"12764_CR45","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.4014\/jmb.1703.03068","volume":"27","author":"S Kim","year":"2017","unstructured":"Kim S, Kim HE, Kang B, Lee YW, Kim H, Chung DK (2017) Lipoteichoic acid isolated from Staphylococcus aureus induces both epithelial-mesenchymal transition and wound healing in HaCaT cells. J Microbiol Biotechnol 27:1820\u20131826. https:\/\/doi.org\/10.4014\/jmb.1703.03068","journal-title":"J Microbiol Biotechnol"},{"key":"12764_CR46","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00262-017-1980-4","volume":"66","author":"K Hattar","year":"2017","unstructured":"Hattar K, Reinert CP, Sibelius U, G\u00f6kyildirim MY, Subtil FSB, Wilhelm J, Eul B, Dahlem G, Grimminger F, Seeger W et al (2017) Lipoteichoic acids from Staphylococcus aureus stimulate proliferation of human non-small-cell lung cancer cells in vitro. Cancer Immunol Immunother 66:799\u2013809. https:\/\/doi.org\/10.1007\/s00262-017-1980-4","journal-title":"Cancer Immunol Immunother"},{"key":"12764_CR47","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.imbio.2014.11.002","volume":"220","author":"JH Jeong","year":"2015","unstructured":"Jeong JH, Jang S, Jung BJ, Jang KS, Kim BG, Chung DK, Kim H (2015) Differential immune-stimulatory effects of LTAs from different lactic acid bacteria via MAPK signaling pathway in RAW 264.7 cells. Immunobiology 220:460\u2013466. https:\/\/doi.org\/10.1016\/j.imbio.2014.11.002","journal-title":"Immunobiology"},{"key":"12764_CR48","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.cyto.2012.10.034","volume":"61","author":"SF Cheng","year":"2013","unstructured":"Cheng SF, Ho JW, Chan KY, Leung TY, Lam HS, Fong ON, Li K, Ng PC (2013) IL-15 and macrophage secretory factors facilitate immune activation of neonatal natural killer cells by lipoteichoic acid. Cytokine 61:499\u2013505. https:\/\/doi.org\/10.1016\/j.cyto.2012.10.034","journal-title":"Cytokine"},{"key":"12764_CR49","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1002\/eji.202048953","volume":"51","author":"O Demaria","year":"2021","unstructured":"Demaria O, Gauthier L, Debroas G, Vivier E (2021) Natural killer cell engagers in cancer immunotherapy: next generation of immuno-oncology treatments. Eur J Immunol 51:1934\u20131942. https:\/\/doi.org\/10.1002\/eji.202048953","journal-title":"Eur J Immunol"},{"key":"12764_CR50","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1189\/jlb.1005616","volume":"79","author":"KJ Lubick","year":"2006","unstructured":"Lubick KJ, Jutila MA (2006) LTA recognition by bovine \u03b3\u03b4 T cells involves CD36. J Leukoc Biol 79:1268\u20131270. https:\/\/doi.org\/10.1189\/jlb.1005616","journal-title":"J Leukoc Biol"},{"key":"12764_CR51","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1189\/jlb.0907656","volume":"84","author":"NJ Nilsen","year":"2008","unstructured":"Nilsen NJ, Deininger S, Nonstad U, Skjeldal F, Husebye H, Rodionov D, von Aulock S, Hartung T, Lien E, Bakke O, Espevik T (2008) Cellular trafficking of lipoteichoic acid and Toll-like receptor 2 in relation to signaling: role of CD14 and CD36. J Leukoc Biol 84:280\u2013291. https:\/\/doi.org\/10.1189\/jlb.0907656","journal-title":"J Leukoc Biol"},{"key":"12764_CR52","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.4049\/jimmunol.170.3.1406","volume":"170","author":"G Melmed","year":"2003","unstructured":"Melmed G, Thomas LS, Lee N, Tesfay SY, Lukasek K, Michelsen KS, Zhou Y, Hu B, Arditi M, Abreu MT (2003) Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J Immunol 170:1406\u20131415. https:\/\/doi.org\/10.4049\/jimmunol.170.3.1406","journal-title":"J Immunol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12764-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12764-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12764-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:00:32Z","timestamp":1789560032000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12764-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12764"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12764-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study used established cell lines and did not involve human participants, human tissue samples, or animal experiments.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1583"}}